Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
Poly Medicure Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Poly Medicure to invest 60 cr in new facility in Haryana
Aims to tap potential in domestic market Poly Medicure to foray into renal, blood banking products
Poly Medicure, manufacturer of medical devices and disposables under the Polymed' brand, is foraying into renal, respiratory and blood banking segments besides expanding its dealership network in Tamil Nadu, a senior company official said. Poly Medicure launches new products
Poly Medicure Ltd, manufacturer of medical devices and disposables, has launched products for renal, respiratory & blood banking sector under the brand name Polymed. The company plans to tap the ... Outcome of ESOP Compensation Committee Meeting
Poly Medicure Ltd has informed BSE regarding Outcome of ESOP Compensation Committee Meeting held on June 02, 2016. Form A for March 31, 2016
Poly Medicure Ltd has informed BSE about : 1. Standalone Form A for the period ended March 31, 2016 Board recommends Final Dividend
Poly Medicure Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 13, 2016, inter alia, has Recommendation of Final Dividend of Rs. 0.50 (fifty paise) per Equity Shares of Rs. 5 each for the Financial Year 2015-16 subject to approval of shareholders. Standalone & Consolidated Financial Results, Auditors Report for March 31, 2016
Poly Medicure Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Consolidated Financial Results for the period ended March 31, 20163. Standalone Auditors Report for the period ended March 31, 20164. Consolidated Auditors Report for the period ended March 31, 2016 Board to consider Dividend
Poly Medicure Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 13, 2016, inter alia:1. To consider and approve the Audited Financial Results (Consolidated & Standalone) of the Company for the financial year ended on March 31, 2016.2. To consider recommendation of Dividend, if any, on the Equity Shares for the financial year ended on March 31, 2016....